dr n. med. Marek Cieśla

Publikacje

• [współaut.] Darmochwał-Kolarz D, Kubis H, Kolarz B Digital PCR-Based Assessment of Piwi-RNA PIR35982 as a Supporting Biomarker in Rheumatoid Arthritis. - Journal of Inflammation Research, 2025, Vol. 18, p. 10995-11007
• [współaut.] Darmochwał-Kolarz D, Kubis H, Kolarz B MiRNA-186 as a Biomarker of Disease Exacerbation in Rheumatoid Arthritis : Insights from Clinical Data and Molecular Marker Analysis. - International Journal of Molecular Sciences, 2025, Vol. 26, iss. 16
• [współaut.] Kunysz M, Mora-Janiszewska O, Darmochwał-Kolarz D Reduced Methylation of IRF5 Gene as a Biomarker for Gestational Diabetes Mellitus. - Medical Science Monitor, 2025, Vol. 31
• [współaut.] Mołoń A, Podgórska D, Płonka A [et al.] Upregulation of HOTTIP and Its Potential Role in Monitoring Exercise Adaptation. - International Journal of Molecular Sciences, 2025, Vol. 26, iss. 16
• [współaut.] Dłuski D, Darmochwał-Kolarz D Circular RNA hsa_circ_0002268 (PHACTR1) Is Specific to Gestational Diabetes Mellitus in a Polish Pregnant Population. - International Journal of Molecular Sciences, 2024, Vol. 25, iss. 13
• [współaut.] Darmochwał-Kolarz D, Kwaśniak K, Pałka A [et al.] Plasma Circular-RNA 0005567 as a Potential Marker of Disease Activity in Rheumatoid Arthritis. - International Journal of Molecular Sciences, 2024, Vol. 25, iss. 1
• [współaut.] Darmochwał-Kolarz D, Pałka A, Łagowska K [et al.] Expression of NEAT1, PACERR, and GAS5 circulating long noncoding RNAs can be associated with disease activity in rheumatoid arthritis patients. - Polskie Archiwum Medycyny Wewnętrznej, 2024, Vol. 134, iss. 12
• [współaut.] Gil-Kulik P, Kluz N, Przywara D [et al.] Potential Use of Exosomal Non-Coding MicroRNAs in Leukemia Therapy : A Systematic Review. - Cancers, 2024, Vol. 16, iss. 23
• [współaut.] Kunysz M, Darmochwał-Kolarz D Evaluation of miRNA Expression in Patients with Gestational Diabetes Mellitus : Investigating Diagnostic Potential and Clinical Implications. - Diabetes, Metabolic Syndrome and Obesity-Targets and Therapy, 2024, Vol. 17, p. 881-891
• [współaut.] Myszka A, Siekierzyńska A, Sendera A [et al.] Predictive Molecular Biomarkers of Bladder Cancer Identified by Next-Generation Sequencing : Preliminary Data. - Journal of Clinical Medicine, 2024, Vol. 13, no. 24
• [współaut.] Och A, Lemieszek M, Jedrejek D [et al.] Berberis vulgaris L. Root Extract as a Multi-Target Chemopreventive Agent against Colon Cancer Causing Apoptosis in Human Colon Adenocarcinoma Cell Lines. - International Journal of Molecular Sciences, 2024, Vol. 25, iss. 9
• [współaut.] Podgórska D, Płonka A, Bajorek W [et al.] Changes in Circulating MicroRNA Levels as Potential Indicators of Training Adaptation in Professional Volleyball Players. - International Journal of Molecular Sciences, 2024, Vol. 25, iss. 11
• [współaut.] Och A, Olech M, Bąk K [et al.] Evaluation of the Antioxidant and Anti-Lipoxygenase Activity of Berberis vulgaris L. Leaves, Fruits, and Stem and Their LC MS/MS Polyphenolic Profile. - Antioxidants, 2023, Vol. 12, iss. 7
• [współaut.] Kolarz B, Darmochwał-Kolarz D The lack of association between PADI4_94 or PADI4_104 polymorphisms and RF, ACPA and anti-PAD4 in patients with rheumatoid arthritis. - Scientific Reports, 2022, Vol. 12, iss. 1
• [współaut.] Kolarz B, Majdan M, Darmochwał-Kolarz D Plasma micro-RNA-22 is associated with disease activity in well-established rheumatoid arthritis. - Clinical and Experimental Rheumatology, 2022, Vol. 40, no. 5, p. 945-951
• [współaut.] Podgórska D, Kolarz B FCER1G Gene Hypomethylation in Patients with Rheumatoid Arthritis. - Journal of Clinical Medicine, 2022, Vol. 11, no. 16
• [współaut.] Podgórska D, Majdan M, Podgórski R [et al.] The relationship of ADAMTSL2 and LRPAP1 gene methylation level with rheumatoid arthritis activity. - Clinical and Experimental Rheumatology, 2022, Vol. 40, no. 11, p. 2052-2059
• [współaut.] Podgórski R, Podgórska D, Bajorek W [et al.] Plasma microRNA-320a as a Potential Biomarker of Physiological Changes during Training in Professional Volleyball Players. - Journal of Clinical Medicine, 2022, Vol. 11, no. 1
• [współaut.] Kolarz B, Rosenthal A, Dryglewska M [et al.] The value of anti-CarP and anti-PAD4 as markers of rheumatoid arthritis in ACPA/RF negative rheumatoid arthritis patients. - Therapeutic Advances in Musculoskeletal Disease, 2021, Vol. 13, s. 1-10
• [współaut.] Kolarz B, Dryglewska M, Majdan M Peptidyl Arginine Deiminase Type 4 Gene Promoter Hypo-Methylation in Rheumatoid Arthritis. - Journal of Clinical Medicine, 2020, Vol. 9, no. 7
• [współaut.] Kolarz B, Dryglewska M, Rosenthal A [et al.] Hypermethylation of the miR-155 gene in the whole blood and decreased plasma level of miR-155 in rheumatoid arthritis. - PLoS ONE, 2020, Vol. 15, iss. 3, Article Number: e0233897
• [współaut.] Kolarz B, Majdan M, Darmochwał-Kolarz D Methylation Pattern of the SOCS3 and IL6R Promoters in Rheumatoid Arthritis. - International Journal of Inflammation, 2020, Vol. 2020
• [współaut.] Kolarz B, Majdan M, Darmochwał-Kolarz D IRF5 promoter methylation as a new potential marker of rheumatoid arthritis. - Polskie Archiwum Medycyny Wewnętrznej, 2019, vol. 129, No. 6, s. 370-376